| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 360.52M | — |
| Operating expense | — | — |
| Net income | 83.50M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PTCT returned +38.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -8.1% |
| 1 year | +38.1% |
| 5 years | +60.0% |
| 10 years | +750.4% |
| All-time high | $85.99 (Nov 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PTCT would be worth today ›No. PTC Therapeutics, Inc. has not paid a dividend in the past 12 months.
PTC Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol PTCT.
PTC Therapeutics, Inc. is part of the Healthcare sector.
PTC Therapeutics, Inc. has a market cap of 5.83B USD, based on the latest quote.
